| [1] |
中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志，2020，41(2):145-151.
|
| [2] |
国家中医药管理局办公室.新型冠状肺炎诊疗方案（试行第七版）[EB/OL].（2020-03-04）[2020-03-26].
URL
|
| [3] |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
|
| [4] |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020, doi: 10.1001/jama.2020.1585. |
| [5] |
刘茜，王荣帅，屈国强，等.新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J].法医学杂志，2020，36(1):21-23.
|
| [6] |
Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically Ill patients with covid-19 in Washington State[J]. JAMA, 2020. [Online ahead of print]
|
| [7] |
中国高血压防治指南修订委员会，高血压联盟，中国医师协会高血压专业委员会，等.中国高血压防治指南（2018年修订版）[J].心脑血管病防治，2018，18(1):1-44.
|
| [8] |
Bar A, Olkowicz M, Tyrankiewicz U, et al. Functional and biochemical endothelial profiling in vivo in a murine model of endothelial dysfunction; comparison of effects of 1-methylnicotinamide and angiotensin-converting enzyme inhibitor[J]. Front Pharmacol, 2017, 8:183.
|
| [9] |
|
| [10] |
Caldeira D, Alarcão J, Vaz-Carneiro A, et al. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis[J]. BMJ, 2012, 345:e4260.
|
| [11] |
Kreutz R, Algharably EAE, Azizi M, et al. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19[J]. Cardiovasc Res, 2020. [Online ahead of print].
|
| [12] |
中华医学会心血管病学分会中华心血管病杂志编辑委员会.关于新型冠状病毒肺炎与RAS抑制剂治疗心血管疾病的科学声明[J].中华心血管病杂志，2020，48(2020-04-14):[网络预发表].
|
| [13] |
Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study[J]. J Infect Dis, 2010, 201(3):318-330.
|
| [14] |
Mulangu S, Dodd LE, Davey RT, et al. A randomized, controlled trial of Ebola virus disease therapeutics[J]. N Engl J Med, 2019, 381(24):2293-2303.
|